Greenwich Lifesciences(GLSI.US)

Event Tracking

Jan5

Greenwich Lifesciences CEO and CFO Snehal Patel Acquires Company Shares

11:19

Jan2

Greenwich Lifesciences CEO Announces Acquisition of Company's Common Stock

11:21

Dec29

Greenwich LifeSciences Extends Lock-Up Period to Support Immunotherapy Trial

11:00

Nov15

Greenwich Lifesciences released FY2025 9 Months earnings on November 14 (EST), actual revenue USD 0, actual EPS USD -0.8527

04:00

Greenwich Lifesciences released FY2025 Q3 earnings on November 14, 2025 (EST), with actual revenue of USD 0 (forecast USD 0) and actual EPS of USD -0.3043 (forecast USD -0.36)

04:00

Oct9

Greenwich Life Sciences Assessing Preventative Breast Cancer Immunotherapy GLSI-100

10:37

Schedules & Filings

Schedules

Filings

Nov14

Earning Release(EST)

FY2025 Q3 Earning Release (USD) Net Income -4.152 M, EPS -0.3043

Aug14

Earning Release(EST)

FY2025 Q2 Earning Release (USD) Net Income -4.025 M, EPS -0.301

May20

Earning Release(EST)

FY2025 Q1 Earning Release (USD) Net Income -3.258 M, EPS -0.2473

Stock List

Top Gainers

Top Decliners

China Concepts

Symbol

Price

%Chg

Change